ELASTAGEN
Elastagen is a clinical stage medical company with an advanced pipeline of products based on the human protein tropoelastin, a pioneering medical biomaterial. Elastin is a critical component of tissues in the human body which require the ability to stretch and recoil, such as the skin, lungs, arteries, elastic ligaments. Elastagen has developed a synthetic version of the elastin protein which is identical to that naturally present in the human body. Elastagenโs platform technology has... potential applications in a number of areas including skin rejuvenation, scar remodelling and tissue repair. Elastagen was founded following the acquisition of intellectual property rights to the elastin technology which was developed by Prof Weiss at the University of Sydney. The Company has since successfully attracted capital from a number of leading Australian and overseas life science venture capital groups. Elastagenโs operations have expanded from its Australian base to include production in Europe and clinical operations in the UK.
ELASTAGEN
Industry:
Biotechnology Clinical Trials Medical Medical Device
Founded:
2003-01-01
Address:
Sydney, New South Wales, Australia
Country:
Australia
Website Url:
http://www.elastagen.com
Total Employee:
1+
Status:
Active
Contact:
+61 (0)2 9209 4054
Email Addresses:
[email protected]
Total Funding:
15.12 M USD
Technology used in webpage:
SPF Mobile Non Scaleable Content Microsoft Exchange Online Office 365 Mail Dreamscape Networks
Current Advisors List
Current Employees Featured
Founder
Investors List
Medical Devices Fund
Medical Devices Fund investment in Grant - Elastagen
Korea Investment Partners
Korea Investment Partners investment in Series B - Elastagen
Wellcome Trust
Wellcome Trust investment in Series B - Elastagen
GBS Ventures
GBS Ventures investment in Series B - Elastagen
Brandon Capital Partners
Brandon Capital Partners investment in Series B - Elastagen
Cicada Innovations
Cicada Innovations investment in Series B - Elastagen
AMOREPACIFIC Ventures
AMOREPACIFIC Ventures investment in Series B - Elastagen
Cicada Innovations
Cicada Innovations investment in Seed Round - Elastagen
Official Site Inspections
http://www.elastagen.com
- Host name: ip74001436.ipv4.syd02.ds.network
- IP address: 116.0.20.54
- Location: Australia
- Latitude: -33.494
- Longitude: 143.2104
- Timezone: Australia/Sydney